Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Neurosci Biobehav Rev. 2018 Nov 22;99:160–197. doi: 10.1016/j.neubiorev.2018.11.010

Table A.5.

Non-Human Study Quality and Risk of Bias Assessment*.

Reference 1 2 3 4 5 6 7 8 9 10 11 12 Total
Scorea
Rat (Rattus)
(Nimgampalle and Kuna, 2017) 1 0 1 1 1 1 0 0 0 0 0 0 5
(Liang et al., 2017) 1 1 0 1 0 1 0 1 0 0 0 1 6
(Abildgaard et al., 2017a) 1 1 0 1 1 1 0 1 1 1 0 1 9
(Abildgaard et al., 2017b) 1 1 0 1 1 1 0 1 1 1 0 1 9
(Tillmann et al., 2018) 1 1 0 1 1 1 0 1 1 1 1 1 10
(Messaoudi et al., 2011a) 1 1 1 1 1 1 1 1 NA 0 0 1 9
(Desbonnet et al., 2008) 1 1 0 1 1 1 0 1 0 0 0 1 7
(Liang et al., 2015) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Beilharz et al., 2017) 1 1 0 1 1 1 0 1 0 0 0 1 7
(Davari et al., 2013) 1 1 0 1 1 1 0 0 NA 0 0 0 5
(Goudarzvand et al., 2016) 0 1 1 1 1 1 0 0 NA 0 0 0 5
(Jeong et al., 2015) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Wang et al., 2015) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Distrutti et al., 2014) 1 1 0 1 1 1 0 0 0 0 0 0 5
(Arseneault-Breard et al., 2012) 1 1 0 1 1 1 1 1 NA 0 0 1 8
(Luo et al., 2014) 1 1 0 1 1 1 0 1 0 0 0 0 6
(Callaghan et al., 2016) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Cowan et al., 2016) 1 0 0 1 1 1 0 1 0 0 0 1 6
(Desbonnet et al., 2010) 1 1 1 1 1 1 0 1 1 0 0 1 9
(Gilbert et al., 2013) 1 1 0 1 1 1 0 1 NA 0 0 0 6
(McKernan et al., 2010) 1 1 0 1 1 1 0 0 0 0 0 0 5
(Vanhaecke et al., 2017) 1 1 0 1 1 0 0 1 NA 0 0 0 5
(Athari Nik Azm et al., 2018) 1 0 0 1 1 1 0 0 NA 0 0 1 5
(McVey Neufeld et al., 2017) 1 1 0 1 1 1 0 0 NA 0 0 1 6
Mouse (Mus)
(Musa et al., 2017) 1 1 1 1 1 1 0 0 NA 0 0 0 6
(Guida et al., 2017) 1 1 0 1 1 1 0 1 0 0 0 1 7
(Jeong et al., 2016) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Dhaliwal et al., 2018) 1 1 1 1 1 1 0 0 0 0 0 1 7
(Divyashri et al., 2015) 1 1 1 1 1 1 0 0 1 0 0 1 8
(Hsiao et al., 2013) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Bharwani et al., 2017) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Emge et al., 2016) 1 1 0 1 1 1 0 0 0 0 0 1 6
(Bercik et al., 2010) 1 1 1 1 1 1 0 0 0 1 0 1 8
(Bercik et al., 2011) 1 1 1 1 1 1 0 1 0 0 0 1 8
(Savignac et al., 2015) 1 1 1 1 1 1 0 0 0 0 0 1 7
(Mohle et al., 2016) 1 1 0 1 1 1 0 1 1 0 0 0 7
(Gareau et al., 2011) 1 1 0 1 1 0 1 1 0 0 0 0 6
(Smith et al., 2014) 1 1 0 1 1 0 0 0 0 0 0 1 5
(Woo et al., 2014) 1 1 1 1 1 1 0 0 0 0 0 1 7
(Buffington et al., 2016) 1 1 1 1 1 1 0 0 0 0 0 0 6
(D'Mello et al., 2015) 1 1 1 1 1 1 1 1 0 0 0 0 8
(Savignac et al., 2014) 1 1 0 1 1 1 0 0 NA 0 0 0 5
(Bravo et al., 2011) 1 1 0 1 1 1 0 1 0 0 0 1 7
(Kantak et al., 2014) 1 1 1 1 1 1 1 1 0 0 0 0 8
(Xiao et al., 2014) 1 1 1 1 1 1 0 1 0 0 0 1 8
(Tian et al., 2017) 1 1 1 1 1 1 0 0 NA 0 0 0 6
(Ohland et al., 2013) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Liu et al., 2016a) 1 1 0 1 1 1 0 0 0 0 0 1 6
(Liu et al., 2016b) 1 1 1 1 1 1 0 0 0 0 0 0 6
(Sun et al., 2016) 1 1 1 1 1 1 0 0 0 0 0 1 7
Zebrafish (Danio rerio)
(Davis et al., 2016a) 1 1 1 1 1 0 0 0 0 0 0 0 5
(Davis et al., 2016b) 1 1 0 1 1 0 0 0 0 0 0 0 4
(Schneider et al., 2016) 1 1 1 1 1 1 0 0 0 0 0 1 7
(Borrelli et al., 2016) 1 1 1 1 1 0 0 0 1 0 0 0 6
(Lim et al., 2017) 1 1 1 1 1 1 0 0 NA 0 0 0 6
Quail (Coturnix japonica)
(Parois et al., 2017) 1 1 1 1 1 0 0 0 0 0 0 1 6

Abbreviations: NA = Not Applicable

a

Mean total score = 6.5 (SD 1.3). Interquartile range 5.5-7.5.

*

Study quality was assessed with a modified scale reported by Macleod et al. (2004). Our customized scale was operationalized as 1 = Yes, 0 = No or Unsure, NA = Not Applicable for each item as follows: 1) compliance with animal welfare regulations; 2) comprehensive statement of environmental control (temperature, handling, etc.); 3) confirmation of probiotic activity prior to administration; 4) exact animal strain and experimental paradigm noted; 5) exact probiotic treatment (including substrain) noted; 6) control group received probiotic vehicle; 7) individuals administering probiotic were blind to treatment groups; 8) behavioral assays conducted blind to treatment; 9) animals tested in a random order when conducting multiple behavioral assays; 10) a priori power analyses for treatment group sample sizes; 11) a priori primary and secondary outcomes; and 12) acknowledged conflicts of interest or lack thereof.